An unnamed care provider has added $20m to the $80m the software-based therapeutics developer received from investors including Novartis and SoftBank in December.

Access Biotechnology and returning investor Eli Lilly were among the participants in a series B round for the RNA-based drug developer.

Fidelity Management and Research co-led a round that more than doubled the Amazon, Comcast and American Express-backed grocery delivery service's valuation to $39bn.

Atlantia, Continental, Intel Capital, Klocke, NTTVC and Tokyo Century were among the investors in a round that took the air taxi developer’s overall funding to near $390m.

Xenotransplantation technology developer eGenesis took its total funding to $263m in a series C round backed by Bayer and Fresenius Medical Care.

GV returned for a series C round that helped the precision cancer medicine developer increase its overall funding to over $180m.

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

Condé Nast and Kering joined new and returning investors to back a round valuing the fashion item resale platform in excess of $1bn.

SoftBank and Microsoft have helped the last-mile delivery service increase its valuation to roughly $2bn in a round led by CapSur Capital.

China Unicom has helped the Shanghai Electric-backed computer chip developer close a series C round that will fund commercialisation and research and development.